Refine by
Drug Metabolism Articles & Analysis
19 news found
Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...
Focus on Pharmacokinetics and Toxicology Understanding a drug's absorption, distribution, metabolism, and excretion (ADME) in animal bodies is crucial for determining appropriate dosages and minimizing adverse effects. CD Formulation's pharmacokinetic services provide detailed analyses of these processes, catering to the distinct metabolic ...
First, the team would conduct extensive preclinical investigations to ascertain the safety and effectiveness of the oral thin films. Factors like drug release kinetics, absorption, metabolism, and possible toxicity during the preclinical stage would be assessed. Next, the absorption, distribution, metabolism and excretion of oral film ...
These microneedles are composed of a biocompatible material that dissolves upon insertion, allowing for controlled and targeted drug release. The dissolving microneedle preparation services offered by CD Formulation provide a comprehensive solution for pharmaceutical companies looking to optimize drug delivery. ...
This enzyme plays a fundamental role in various biological processes including gene expression, protein function, and metabolic activity. Thus, having a quality and reliable source of SAHH is vital for research institutions and industries to advance their understanding and application of this pivotal enzyme. ...
This critical step in the drug development process refers to the systematic evaluation of the safety of therapeutic drugs through laboratory studies and animals in vitro. ...
Araris Biotech AG, a company pioneering antibody-drug conjugate (ADC)-linker technology, announced today that it has recruited Dr. ...
Tumor drug resistance has long been a key direction of cancer research. Meanwhile, complex factors and multiple mechanisms are known to induce drug resistance occurrence or reoccurrence, covering tumor heterogeneity, DNA damage repair, apoptosis inhibition, epithelial-mesenchymal transition, increased drug excretion or reduced absorption, ...
In the paper, ‘Predicting Regioselectivity of AO, CYP, FMO and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning’, the team combined existing experimental results, quantum mechanics and machine learning to build predictive models for drug metabolism. [1] The research will underpin the development of new ...
Choosing the most appropriate delivery system has tremendous benefits, including but not limited to controlled release of drugs, enhanced drug targeting, improved solubility and bioavailability of drugs. In the past decade, several new drug delivery systems have been formulated, in the hope to provide promising alternative routes ...
After digestion, the amino acid sequence may undergo further amino acid modifications and be metabolized by hepatic P450 enzymes. In vivo metabolite studies of protein/peptide drugs usually focus on non-specific enzymatic cleavage or modification of amino acids, P450 enzyme metabolism, and multi-charge distribution. Metabolite identification of ...
Immediate applications of Lifespin’s commercial services, which leverages access to Lifespin’s proprietary software and database, include quality control for synthetic/natural compounds, quantitative profiling of metabolites in liquid samples, monitoring of drug responses and organ-specific metabolic phenotyping, and precision nutrition to therapeutic ...
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the quality of life, today announced a strategic collaboration agreement in Artificial Intelligence for new drug design. ...
ByIktos
Today it announces to add pharmaceutical and drug standards to its already rich offering of chromatography standards. ...
Maureen Bunger, Senior Product Manager, ADME-Tox Solutions, Lonza Cell and Gene, commented: “Today’s drug discovery success is hugely dependent on performing experiments using the right biological model to best reflect in vivo environments. ...
The in silico platform reduces the cost and timeframe of drug development by reducing the need for iterative pre-clinical experiments and better directing clinical trials, while increasing the effectiveness of the therapeutics themselves. ...
“There are a great number of underlying mechanisms that can trigger a cardiac arrest, such as an airway obstruction, a metabolic imbalance, a drug overdose, a critical bleeding, a collapsed lung,” says Frost. ...
“If any clinician is going to provide precision medicine, they’ll need to know the ability of the liver and kidneys to metabolize and eliminate drugs,” he emphasizes. More than 110,000 people are estimated to die each year from adverse drug reactions, which is when the correct drug is given in an appropriate ...
'According to the study the glutathione S-transferases act to inactivate chemicals so people without these GSTM1 and GSTT1 genes are less able to metabolize environmental chemicals,” said Lourdes Salvador, Founder and President of MCS America. “If a person cannot metabolize chemicals they build up in the body and cause disturbances in normal body function,” added ...